CROX vs EW · rev $4.10B vs P/E 47, rev $1.39B
Crocs Inc (CROX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CROX currently screens at market cap $5.93B. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CROX and EW stock pages for the full models.
Not investment advice.